Cerenome (CNSY) EBIT Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBIT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -1,651.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 29,091.00 |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -209,300.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -209,300.00 |
| Mar 31, 2026 | -35,861.00 |
| Dec 31, 2025 | -14,384.00 |
| Sep 30, 2025 | -5,991.00 |
| Jun 30, 2025 | 17,841.00 |
| Mar 31, 2025 | -13,718.00 |
| Dec 31, 2024 | 1,763.00 |
| Sep 30, 2024 | -18,703.00 |
| Jun 30, 2024 | -21,063.00 |
| Mar 31, 2024 | 73,648.00 |
| Dec 31, 2023 | 339,624.00 |
| Sep 30, 2023 | 690,420.00 |
| Mar 31, 2019 | 28,724.00 |
| Dec 31, 2018 | 41,402.00 |
| Sep 30, 2018 | 67,042.00 |
| Jun 30, 2018 | 29,626.00 |
| Mar 31, 2018 | 61,091.00 |
| Dec 31, 2017 | -30,345.00 |
| Sep 30, 2017 | -27,375.00 |
| Jun 30, 2017 | -2,320.00 |